Sustainability Report

Overview

The report covers Centrient Pharmaceuticals' environmental, social and governance performance for 2018-2019, highlighting its first EcoVadis Gold sustainability rating in 2019 and top 4% industry ranking. It reports that the company's largest semi-synthetic penicillin API portfolio met AMR Industry Alliance PNEC targets two years ahead of schedule. The report also presents 2019 energy consumption of 4,461 TJ and combined Scope 1 and 2 CO2 emissions of 328,742 tonnes/year, while the workforce totaled 2,700 including third-party employees.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2019
Period: 1 January 2018 – 31 December 2019
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services